Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Edwards Lifesciences ( (EW) ) has provided an update.
On August 19, 2025, Edwards Lifesciences Corporation announced its entry into an accelerated share repurchase agreement, which may impact its financial strategies and shareholder value.
The most recent analyst rating on (EW) stock is a Buy with a $88.00 price target. To see the full list of analyst forecasts on Edwards Lifesciences stock, see the EW Stock Forecast page.
Spark’s Take on EW Stock
According to Spark, TipRanks’ AI Analyst, EW is a Outperform.
Edwards Lifesciences’ strong earnings call performance and robust financial health are the primary drivers of its stock score. The company’s positive sales growth and increased guidance highlight its growth potential. However, the high P/E ratio and cash flow challenges slightly temper the overall score.
To see Spark’s full report on EW stock, click here.
More about Edwards Lifesciences
Average Trading Volume: 4,214,328
Technical Sentiment Signal: Buy
Current Market Cap: $45.95B
For an in-depth examination of EW stock, go to TipRanks’ Overview page.